Category Archives: spine

Clinical applications of medical/surgical sealants and glues

The applications of surgical sealants, glues and wound closure are many and are rapidly multiplying as more credible data is generated on each application and as physicians gain comfort in working with the products in routine clinical practice.
Below is a sample of surgical sealants, glues and wound closure applications by clinical area:

Source: MedMarket Diligence, LLC; [...]

Orthopedics and Skin/Integumentary with most clinical applications in tissue engineering and cell therapy

The use of autologous, allogeneic and xenogeneic cells and tissues, the use of biomaterials, cell scaffolding and other approaches to tissue repair and regeneration has become part of arsenal of a number of clinical specialties, with high caseload and market revenue in these areas.  In particular, orthopedics and skin applications are well established.  And, while [...]

Report: Worldwide Tissue Engineering & Cell Therapy Market at $6.9 billion

Our research into the products, technologies, companies and markets for tissue engineering and cell therapy has revealed that the 2009 market was at $6.9 billion. The market has grown dramatically, in commercialized products and company activity, over the past few years and is on an accelerated growth rate as technology hurdles are overcome and clinical [...]

Revenues in Cell Therapy and Tissue Engineering Exceeding Expectations

The number of companies with approved products and measurable revenues in the field of cell therapy and tissue engineering has exceeded the expectation of many (though not all) in the industry.
Markets such as cell/tissue are often characterized by overestimated evaluations of commercial potential and underestimated consideration of the actual challenges. Indeed many technology challenges remain [...]

Aggressive development of spine technologies and markets

One of the most active areas of medical technology development over the past decade has been in the area of spine surgery technologies.  Numerous companies have been founded (and only a few have since folded) to pursue applications in the treatment (and diagnosis) of spine disease, disorders and trauma.  These range from "traditional" spine fusion [...]

Technologies at medtech startups, November 2009

Below are select technologies under development at recently identified medtechs startups:

Scaffold for regeneration of functional bone tissues.
Autologous, adipose-derived stem cells for treatment of traumatic brain injury and chronic obstructive pulmonary disease.
Device company developing technologies to improve the safety and efficiency of chemotherapy.
Developing stem cell therapies.
Devices to locate and protect nerves during surgery.
Minimally invasive (endoscopic) spine [...]

Medtech: Where is the opportunity?

The areas of greatest opportunity in medtech are those which have already demonstrated they have plenty of upside, even if a robust number of competitors have already begun targeting them.
Areas of the strongest market growth in medical technologies that we are seeing have emerged out of the major segments we have tracked in recent analyses. [...]

Dynamic stabilization in spine surgery under the FDA’s scrutiny for postmarket surveillance

The FDA announced that it has ordered manufacturers of dynamic stabilization systems (pedicle screw) to begin postmarket surveillance studies to compare dynamic stabilization to traditional stabilization systems relative to fusion rates, adverse events, subsequent surgical procedures, cause of failures of the systems.
From Medical News Today:

Dynamic stabilization systems are used in spinal surgery and some [...]

Spine surgery technologies: changes in market composition

 
Markets for products in spine surgery show a decline in spine fusion and total disc replacement, but an increase in intraspinous process spacers and nucleus replacement.  Although the exhibit below displays this only for Asia/Pacific markets, the trend is true globally.

Source:  Exhibit 3-107 is taken from MedMarket Diligence report #M510, "Spine Surgery: Products, Technologies, Markets & [...]

DuraSeal(TM) Spine Sealant Receives FDA Approval

Covidien gained FDA approval this week for its DuraSeal for the sealing of sutured dural tears, which occur in 10% of all spinal fusion procedures.  (See DuraSeal(TM) Spine Sealant Receives FDA Approval.) 

DuraSeal, originally developed by Confluent Surgical, is a PEG (polyethylene glycol) solution and a trilysine amine solution, that has been shown effective in preventing intra-operative and post-operative [...]